BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19251824)

  • 1. The major human pregnane X receptor (PXR) splice variant, PXR.2, exhibits significantly diminished ligand-activated transcriptional regulation.
    Lin YS; Yasuda K; Assem M; Cline C; Barber J; Li CW; Kholodovych V; Ai N; Chen JD; Welsh WJ; Ekins S; Schuetz EG
    Drug Metab Dispos; 2009 Jun; 37(6):1295-304. PubMed ID: 19251824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways.
    Cerveny L; Svecova L; Anzenbacherova E; Vrzal R; Staud F; Dvorak Z; Ulrichova J; Anzenbacher P; Pavek P
    Drug Metab Dispos; 2007 Jul; 35(7):1032-41. PubMed ID: 17392393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of pregnane X receptor (PXR) and constitutive androstane receptor (CAR) activation by ursolic acid (UA) attenuates rifampin-isoniazid cytotoxicity.
    Chang HY; Chen CJ; Ma WC; Cheng WK; Lin YN; Lee YR; Chen JJ; Lim YP
    Phytomedicine; 2017 Dec; 36():37-49. PubMed ID: 29157826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycyclic aromatic hydrocarbons stimulate human CYP3A4 promoter activity via PXR.
    Luckert C; Ehlers A; Buhrke T; Seidel A; Lampen A; Hessel S
    Toxicol Lett; 2013 Oct; 222(2):180-8. PubMed ID: 23845848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower expression of HNF4α and PGC1α might impair rifampicin-mediated CYP3A4 induction under conditions where PXR is overexpressed in human fetal liver cells.
    Takezawa T; Matsunaga T; Aikawa K; Nakamura K; Ohmori S
    Drug Metab Pharmacokinet; 2012; 27(4):430-8. PubMed ID: 22333269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pregnane X receptor regulates gene expression in a ligand- and promoter-selective fashion.
    Masuyama H; Suwaki N; Tateishi Y; Nakatsukasa H; Segawa T; Hiramatsu Y
    Mol Endocrinol; 2005 May; 19(5):1170-80. PubMed ID: 15650019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel distal enhancer module regulated by pregnane X receptor/constitutive androstane receptor is essential for the maximal induction of CYP2B6 gene expression.
    Wang H; Faucette S; Sueyoshi T; Moore R; Ferguson S; Negishi M; LeCluyse EL
    J Biol Chem; 2003 Apr; 278(16):14146-52. PubMed ID: 12571232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. U0126, a mitogen-activated protein kinase kinase 1 and 2 (MEK1 and 2) inhibitor, selectively up-regulates main isoforms of CYP3A subfamily via a pregnane X receptor (PXR) in HepG2 cells.
    Smutny T; Bitman M; Urban M; Dubecka M; Vrzal R; Dvorak Z; Pavek P
    Arch Toxicol; 2014 Dec; 88(12):2243-59. PubMed ID: 24819614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of residues T248, Y249 and T422 in the function of human pregnane X receptor.
    Doricakova A; Novotna A; Vrzal R; Pavek P; Dvorak Z
    Arch Toxicol; 2013 Feb; 87(2):291-301. PubMed ID: 22976785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pregnane X receptor binds to response elements in a genomic context-dependent manner, and PXR activator rifampicin selectively alters the binding among target genes.
    Song X; Xie M; Zhang H; Li Y; Sachdeva K; Yan B
    Drug Metab Dispos; 2004 Jan; 32(1):35-42. PubMed ID: 14709618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of four naturally occurring variants of human pregnane X receptor (PXR): one variant causes dramatic loss of both DNA binding activity and the transactivation of the CYP3A4 promoter/enhancer region.
    Koyano S; Kurose K; Saito Y; Ozawa S; Hasegawa R; Komamura K; Ueno K; Kamakura S; Kitakaze M; Nakajima T; Matsumoto K; Akasawa A; Saito H; Sawada J
    Drug Metab Dispos; 2004 Jan; 32(1):149-54. PubMed ID: 14709632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fucoxanthin attenuates rifampin-induced cytochrome P450 3A4 (CYP3A4) and multiple drug resistance 1 (MDR1) gene expression through pregnane X receptor (PXR)-mediated pathways in human hepatoma HepG2 and colon adenocarcinoma LS174T cells.
    Liu CL; Lim YP; Hu ML
    Mar Drugs; 2012 Jan; 10(1):242-257. PubMed ID: 22363234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Gene Regulation by Dual Ligands of Nuclear Receptors Constitutive Androstane Receptor (CAR) and Pregnane X Receptor (PXR) in HepG2 Cells Stably Expressing CAR/PXR.
    Kanno Y; Tanuma N; Yazawa S; Zhao S; Inaba M; Nakamura S; Nemoto K; Inouye Y
    Drug Metab Dispos; 2016 Aug; 44(8):1158-63. PubMed ID: 27197997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha. Functional implications in hepatic cholesterol and glucose metabolism.
    Bhalla S; Ozalp C; Fang S; Xiang L; Kemper JK
    J Biol Chem; 2004 Oct; 279(43):45139-47. PubMed ID: 15322103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous substitution of phenylalanine-305 and aspartate-318 of rat pregnane X receptor with the corresponding human residues abolishes the ability to transactivate the CYP3A23 promoter.
    Song X; Li Y; Liu J; Mukundan M; Yan B
    J Pharmacol Exp Ther; 2005 Feb; 312(2):571-82. PubMed ID: 15367577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnane X receptor polymorphism affects CYP3A4 induction via a ligand-dependent interaction with steroid receptor coactivator-1.
    Lim YP; Huang JD
    Pharmacogenet Genomics; 2007 May; 17(5):369-82. PubMed ID: 17429319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azole antimycotics differentially affect rifampicin-induced pregnane X receptor-mediated CYP3A4 gene expression.
    Svecova L; Vrzal R; Burysek L; Anzenbacherova E; Cerveny L; Grim J; Trejtnar F; Kunes J; Pour M; Staud F; Anzenbacher P; Dvorak Z; Pavek P
    Drug Metab Dispos; 2008 Feb; 36(2):339-48. PubMed ID: 17998298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of pregnane-X receptor target genes and coactivator and corepressor binding to promoter elements in human hepatocytes.
    Hariparsad N; Chu X; Yabut J; Labhart P; Hartley DP; Dai X; Evers R
    Nucleic Acids Res; 2009 Mar; 37(4):1160-73. PubMed ID: 19129222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of c-Jun-N-Terminal Kinase in Pregnane X Receptor-Mediated Induction of Human Cytochrome P4503A4 In Vitro.
    Taneja G; Chu C; Maturu P; Moorthy B; Ghose R
    Drug Metab Dispos; 2018 Apr; 46(4):397-404. PubMed ID: 29440179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression.
    Li T; Chiang JY
    Drug Metab Dispos; 2006 May; 34(5):756-64. PubMed ID: 16455805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.